UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 424

Sortiert nach

Macrophage Metabolism of Apoptotic Cell-Derived Arginine Promotes Continual Efferocytosis and Resolution of Injury

Cell metabolism, 2020-03, Vol.31 (3), p.518-533.e10

2020

Volltextzugriff (PDF)

Mapping the cancer surface proteome in search of target antigens for immunotherapy

Molecular therapy, 2024-07

2024

Volltextzugriff (PDF)

A metabolic perspective on nitric oxide function in melanoma

Biochimica et biophysica acta. Reviews on cancer, 2024-01, Vol.1879 (1), p.189038-189038, Article 189038

2024

Volltextzugriff (PDF)

An immunoproteomic approach to characterize the CAR interactome and signalosome

Science signaling, 2019-02, Vol.12 (568)

2019

Volltextzugriff (PDF)

Metabolomics of primary cutaneous melanoma and matched adjacent extratumoral microenvironment

PloS one, 2020-10, Vol.15 (10), p.e0240849-e0240849

2020

Volltextzugriff (PDF)

Unification of de novo and acquired ibrutinib resistance in mantle cell lymphoma

Nature communications, 2017-04, Vol.8 (1), p.14920-14920, Article 14920

2017

Volltextzugriff (PDF)

Single-cell Characterization of the Cellular Landscape of Acral Melanoma Identifies Novel Targets for Immunotherapy

Clinical cancer research, 2022-05, Vol.28 (10), p.2131-2146

2022

Volltextzugriff (PDF)

Extracellular vesicles from human plasma and serum are carriers of extravesicular cargo—Implications for biomarker discovery

PloS one, 2020-08, Vol.15 (8), p.e0236439-e0236439

2020

Volltextzugriff (PDF)

PTEN Loss Confers BRAF Inhibitor Resistance to Melanoma Cells through the Suppression of BIM Expression

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (7), p.2750-2760

2011

Volltextzugriff (PDF)

Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trial

Nature medicine, 2021-08, Vol.27 (8), p.1410-1418

2021

Volltextzugriff (PDF)

K27-linked ubiquitination of BRAF by ITCH engages cytokine response to maintain MEK-ERK signaling

Nature communications, 2019-04, Vol.10 (1), p.1870-15, Article 1870

2019

Volltextzugriff (PDF)

HDAC8 Regulates a Stress Response Pathway in Melanoma to Mediate Escape from BRAF Inhibitor Therapy

Cancer research (Chicago, Ill.), 2019-06, Vol.79 (11), p.2947-2961

2019

Volltextzugriff (PDF)

H2B Tyr37 phosphorylation suppresses expression of replication-dependent core histone genes

Nature structural & molecular biology, 2012-09, Vol.19 (9), p.930

2012

Volltextzugriff (PDF)

Macrophage-Derived Cholesterol Contributes to Therapeutic Resistance in Prostate Cancer

Cancer research (Chicago, Ill.), 2021-11, Vol.81 (21), p.5477-5490

2021

Volltextzugriff (PDF)

Sirt2 Inhibition Enhances Metabolic Fitness and Effector Functions of Tumor-Reactive T Cells

Cell metabolism, 2020-09, Vol.32 (3), p.420-436.e12

2020

Volltextzugriff (PDF)

HDAC Inhibition Enhances the In Vivo Efficacy of MEK Inhibitor Therapy in Uveal Melanoma

Clinical cancer research, 2019-09, Vol.25 (18), p.5686-5701

2019

Volltextzugriff (PDF)

Cdc45 limits replicon usage from a low density of preRCs in mammalian cells

PloS one, 2011-03, Vol.6 (3), p.e17533-e17533

2011

Volltextzugriff (PDF)

Deciphering Phenotypes from Protein Biomarkers for Translational Research with PIPER

Journal of proteome research, 2023-06, Vol.22 (6), p.2055-2066

2023

Volltextzugriff (PDF)

Chronic acidosis in the tumour microenvironment selects for overexpression of LAMP2 in the plasma membrane

Nature communications, 2015-12, Vol.6 (1), p.8752, Article 8752

2015

Volltextzugriff (PDF)

Noncanonical EphA2 Signaling Is a Driver of Tumor-Endothelial Cell Interactions and Metastatic Dissemination in BRAF Inhibitor‒Resistant Melanoma

Journal of investigative dermatology, 2021-04, Vol.141 (4), p.840-851.e4

2021

Volltextzugriff (PDF)

Proteome-wide Profiling of Clinical PARP Inhibitors Reveals Compound-Specific Secondary Targets

Cell chemical biology, 2016-12, Vol.23 (12), p.1490-1503

2016

Volltextzugriff (PDF)

Translational pathology, genomics and the development of systemic therapies for acral melanoma

Seminars in cancer biology, 2020-04, Vol.61, p.149-157

2020

Volltextzugriff (PDF)

Network models of protein phosphorylation, acetylation, and ubiquitination connect metabolic and cell signaling pathways in lung cancer

PLoS computational biology, 2023-03, Vol.19 (3), p.e1010690-e1010690

2023

Volltextzugriff (PDF)

Targeted Peptide Measurements in Biology and Medicine: Best Practices for Mass Spectrometry-based Assay Development Using a Fit-for-Purpose Approach

Molecular & cellular proteomics, 2014-03, Vol.13 (3), p.907-917

2014

Volltextzugriff (PDF)

Phosphoproteomics Reveals MAPK Inhibitors Enhance MET- and EGFR-Driven AKT Signaling in KRAS-Mutant Lung Cancer

Molecular cancer research, 2016-10, Vol.14 (10), p.1019-1029

2016

Volltextzugriff (PDF)

1 – 25 von 424

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(407)
Mit Volltextzugriff
(398)

Publikationsform

Sprache

Englisch
(423)
Japanisch
(75)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(255)
Humans
(191)
Life Sciences & Biomedicine
(166)
Proteomics
(82)
Biochemistry & Molecular Biology
(80)
Multidisciplinary Sciences
(80)
Science & Technology - Other Topics
(80)
Proteins
(77)
Mass Spectrometry
(76)
Animals
(64)
Cell Line, Tumor
(61)
Oncology
(57)
Female
(51)
Male
(47)
Proteomics - Methods
(45)
Biomarkers
(44)
Cancer
(43)
Mass Spectroscopy
(42)
Scientific Imaging
(42)
Biochemical Research Methods
(41)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Macrophage Metabolism of Apoptotic Cell-Derived Arginine Promotes Continual Efferocytosis and Resolution of Injury

Mapping the cancer surface proteome in search of target antigens for immunotherapy

A metabolic perspective on nitric oxide function in melanoma

An immunoproteomic approach to characterize the CAR interactome and signalosome

Metabolomics of primary cutaneous melanoma and matched adjacent extratumoral microenvironment

Unification of de novo and acquired ibrutinib resistance in mantle cell lymphoma

Single-cell Characterization of the Cellular Landscape of Acral Melanoma Identifies Novel Targets for Immunotherapy

Extracellular vesicles from human plasma and serum are carriers of extravesicular cargo—Implications for biomarker discovery

PTEN Loss Confers BRAF Inhibitor Resistance to Melanoma Cells through the Suppression of BIM Expression

Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trial

K27-linked ubiquitination of BRAF by ITCH engages cytokine response to maintain MEK-ERK signaling

HDAC8 Regulates a Stress Response Pathway in Melanoma to Mediate Escape from BRAF Inhibitor Therapy

H2B Tyr37 phosphorylation suppresses expression of replication-dependent core histone genes

Macrophage-Derived Cholesterol Contributes to Therapeutic Resistance in Prostate Cancer

Sirt2 Inhibition Enhances Metabolic Fitness and Effector Functions of Tumor-Reactive T Cells

HDAC Inhibition Enhances the In Vivo Efficacy of MEK Inhibitor Therapy in Uveal Melanoma

Cdc45 limits replicon usage from a low density of preRCs in mammalian cells

Deciphering Phenotypes from Protein Biomarkers for Translational Research with PIPER

Chronic acidosis in the tumour microenvironment selects for overexpression of LAMP2 in the plasma membrane

Noncanonical EphA2 Signaling Is a Driver of Tumor-Endothelial Cell Interactions and Metastatic Dissemination in BRAF Inhibitor‒Resistant Melanoma

Proteome-wide Profiling of Clinical PARP Inhibitors Reveals Compound-Specific Secondary Targets

Translational pathology, genomics and the development of systemic therapies for acral melanoma

Network models of protein phosphorylation, acetylation, and ubiquitination connect metabolic and cell signaling pathways in lung cancer

Targeted Peptide Measurements in Biology and Medicine: Best Practices for Mass Spectrometry-based Assay Development Using a Fit-for-Purpose Approach

Phosphoproteomics Reveals MAPK Inhibitors Enhance MET- and EGFR-Driven AKT Signaling in KRAS-Mutant Lung Cancer

Suchergebnisse filtern